Pfizer epilepsy drug prices were 'unfairly high,' UK review finds https://ift.tt/eA8V8J

In 2016, the CMA fined Pfizer and Flynn a record 90 million pounds ($125 million) for the price hike. However, the companies in 2018 won an appeal against the penalty, and the Competition Appeal Tribunal referred the matter back to the CMA.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3CgU7pB
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.